Biotech

All Articles

Neurocrine's offer to spare mental illness prospect neglects

.Neurocrine Biosciences' schizophrenia system pivot has actually neglected. The biotech was not able...

Sanofi pays out $110M upfront for late-stage radioligand therapy

.Sanofi has made a late access to the radioligand party, paying 100 million europeans ($ 110 million...

F 2G raises $100M for 2nd effort to acquire brand new antifungal to market

.After F2G's first try to obtain a new lesson of antifungal to market was derailed by the FDA, the U...

Moderna targets $1.1 B in R&ampD costs cuts, falls 5 plans amid earnings tensions

.Moderna has actually vowed to reduce R&ampD spending through $1.1 billion by 2027. The choice to re...

Sanofi's $80M bet on Pivot dystrophy drug ends in period 3 go bust

.Only four months after Sanofi wager $80 thousand in ahead of time cash money on Key Therapies' losm...

Oncternal stock sinks 60% amid discharges, test firings

.Cancer cells provider Oncternal Rehabs is folding all its scientific tests and giving up workers, t...

Roche is carrying out hopes that its own injectable obesity possibility could ultimately show 25% weight loss in late-stage trial

.Roche is holding out chances that its own injectable weight problems possibility could eventually d...

Novo Nordisk hails 'impressive' weight loss result for dual-acting oral medication in early trial

.Novo Nordisk has actually lifted the lid on a phase 1 trial of its oral amylin as well as GLP-1 rec...

AbbVie takes legal action against BeiGene over blood stream cancer cells medicine trade secrets

.Merely a handful of brief weeks after succeeding an FDA Fast lane tag for its investigational BTK d...

Lilly delivers one-two blow along with second tranche of beneficial records on weekly the hormone insulin prospect

.Shortly after a good records drop for Eli Lilly's efsitora alfa, the Indianapolis-based provider is...